The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1?, and its interaction with indomethacin
- 1 January 1985
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 29 (4) , 413-416
- https://doi.org/10.1007/bf00613454
Abstract
Pre-incubation of human platelets with nifedipine in vitro or treatment of normal volunteers with nifedipine, 30 mg daily for one week, did not alter ADP induced aggregation measured by whole blood aggregometry. 6-oxo-Prostaglandin F1α remained undetectable in plasma following oral administration of nifedipine to normal volunteers. The hypotensive response to intravenous nifedipine administration was similar in spontaneously hypertensive rats pretreated with indomethacin or placebo. These results conflict with previous reports that nifedipine alters platelet aggregation and prostaglandin metabolism.Keywords
This publication has 19 references indexed in Scilit:
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodPublished by Elsevier ,2002
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- RELEASE OF PROSTACYCLIN IN VIVO AND ITS ROLE IN MANThe Lancet, 1983
- The effects of nifedipine, a calcium antagonist, on platelet functionAmerican Heart Journal, 1983
- Prostacyclin is not a circulating hormone in manProstaglandins, 1982
- High-performance liquid chromatography of nifedipine, its metabolites and photochemical degradation productsJournal of Chromatography A, 1981
- Effects by nifedipine (Adalat®) on platelet function in vitro and in vivoThrombosis Research, 1981
- Patient Participation in a Hypertension Control ProgramJAMA, 1978
- Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary deathAtherosclerosis, 1974
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962